BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10871294)

  • 1. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins.
    Houle S; Landry M; Audet R; Bouthillier J; Bachvarov DR; Marceau F
    J Pharmacol Exp Ther; 2000 Jul; 294(1):45-51. PubMed ID: 10871294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
    Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
    Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration.
    Bertram CM; Baltic S; Misso NL; Bhoola KD; Foster PS; Thompson PJ; Fogel-Petrovic M
    J Leukoc Biol; 2007 Jun; 81(6):1445-54. PubMed ID: 17327486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.
    Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M
    Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.
    Marceau F; Levesque L; Drapeau G; Rioux F; Salvino JM; Wolfe HR; Seoane PR; Sawutz DG
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1136-43. PubMed ID: 8014858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
    Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
    Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical vein: involvement of cyclooxygenase-2 pathway in bradykinin B1 receptor-sensitized responses.
    Errasti AE; Rey-Ares V; Daray FM; Rogines-Velo MP; Sardi SP; Paz C; Podestá EJ; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):149-56. PubMed ID: 11534854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin B1 receptor in isolated human umbilical vein: an experimental model of the in vitro up-regulation process.
    Sardi SP; Errasti AE; Rey-Ares V; Rogines-Velo MP; Rothlin RP
    Acta Pharmacol Sin; 2000 Feb; 21(2):105-10. PubMed ID: 11263256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
    Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of kinin receptors in human cultured detrusor smooth muscle cells.
    Bellucci F; Cucchi P; Santicioli P; Lazzeri M; Turini D; Meini S
    Br J Pharmacol; 2007 Jan; 150(2):192-9. PubMed ID: 17179953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.
    Leeb-Lundberg LM; Marceau F; Müller-Esterl W; Pettibone DJ; Zuraw BL
    Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiles of the human and rabbit B1 receptors.
    Gobeil F; Neugebauer W; Nguyen-Le XK; Nea Allogho S; Pheng LH; Blouin D; Whalley ET; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):591-5. PubMed ID: 9276134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.
    Nowak W; Goldschmidt ED; Falcioni AG; Pugliese MI; Errasti AE; Pelorosso FG; Daray FM; Gago JE; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):221-9. PubMed ID: 17372720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further pharmacological evidence of nuclear factor-kappa B pathway involvement in bradykinin B1 receptor-sensitized responses in human umbilical vein.
    Sardi SP; Rey-Ares V; Pujol-Lereis VA; Serrano SA; Rothlin RP
    J Pharmacol Exp Ther; 2002 Jun; 301(3):975-80. PubMed ID: 12023527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.